T Cell Response in Hypersensitivity Syndrome
NCT00213447 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2013-06-18
Summary
immunological study of the T cell repertoire phenotype and functionality in hypersensitivity syndrome.
Conditions
- Hypersensitivity
- Syndrome
Sponsors & Collaborators
-
University Hospital, Rouen
lead OTHER
Principal Investigators
-
Pascal Joly, MD-PHD · UH rouen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-11-30
- Completion
- 2005-12-31
Countries
- France
Study Locations
More Related Trials
-
Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma
NCT00863395 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Transcriptomics Signature of Anti Vaccinia Memory B Cells
NCT02556489 ·Status: UNKNOWN
-
Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1
NCT02840058 ·Status: COMPLETED ·Phase: NA
-
Study of the Anti-tumoral Immune Response
NCT02854644 ·Status: COMPLETED ·Phase: NA
-
Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs
NCT03984318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2
NCT04836793 ·Status: UNKNOWN
-
Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma
NCT00430053 ·Status: COMPLETED
-
To Identify HLA-A1101-restricted Peptide Epitopes Derived From Novel Oncoantigens (URLC10, KIF20A, and CDCA1) Applicable for Cancer Vaccine in Singapore
NCT01570439 ·Status: UNKNOWN
-
Thymic Function in Patients With COVID-19
NCT04716907 ·Status: COMPLETED
-
Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies
NCT01915992 ·Status: UNKNOWN ·Phase: NA
-
The Role of the Thymus in Type I Diabetes.
NCT03236558 ·Status: WITHDRAWN ·Phase: NA
-
T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study
NCT00986518 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy
NCT04283539 ·Status: RECRUITING
-
Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer
NCT03827343 ·Status: ACTIVE_NOT_RECRUITING
-
Role of Thymus-And Activation-Regulated Chemokine (TARC) In Diagnosis Of Allergic Bronchopulmonary Aspergillosis
NCT03267394 ·Status: UNKNOWN
-
Natural Killer Cells Reconstitution Kinetics Post Haploidentical Transplantation
NCT02978274 ·Status: UNKNOWN
-
Thymosin Alpha-1 for irAE Secondary to ICIs
NCT06178146 ·Status: RECRUITING ·Phase: PHASE4
-
Characterisation of TLR4+ Blood Cells in Patients With Solid Cancer
NCT06131775 ·Status: RECRUITING ·Phase: NA
-
Hyporesponsiveness of Natural Killer Cells and a Dysfunctional Inflammatory Response in Critically Ill Patients
NCT02565589 ·Status: COMPLETED
-
Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection
NCT04362865 ·Status: COMPLETED
-
Efficacy of Low Dose, SubQ Interleukin-2 (IL-2) to Expand Endogenous Regulatory T-Cells in Liver Transplant Recipients
NCT02739412 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of ZW191 in Participants With Solid Tumors
NCT06555744 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy
NCT07198958 ·Status: NOT_YET_RECRUITING
-
A Long Term Follow-up Study of TScan TCR-T Products
NCT06976736 ·Status: RECRUITING
-
Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA
NCT05354765 ·Status: RECRUITING ·Phase: NA